Today, CeMM is home to 8 Principal Investigators and 11 Adjunct Principal Investigators who focus on fundamental questions in molecular medicine. The Principal Investigators include 9 recipients of prestigious ERC grants (Starting Grants: Georg Winter and Davide Seruggia; Consolidator Grants: Andreas Bergthaler, Christoph Bock, Kaan Boztug, Stefan Kubicek and Nuno Maulide; and Advanced Investigator Grants: Giulio Superti-Furga and Andreas Villunger) and two Innovative Medicines Initiative Grants - IMI Resolute and IMI Resolution (Giulio Superti-Furga).
Together we pioneer science that nurtures precise, personalized, predictive, and preventative medicine
In keeping with CeMM's mission to pioneer the science that nurtures the precise, personalized, predictive and preventive medicine of the future, we have a strong connection to clinics. 3 Adjunct Principal Investigators - Kaan Boztug, Thomas Reiberger, Georg Stary - hold Medical Degrees and are performing clinical work alongside their scientific research. In total 8 CeMM Principal Investigators have a dual affiliation with the Medical University of Vienna: Andreas Bergthaler, Christoph Bock, Kaan Boztug, Georg Busslinger, Vanja Nagy, Thomas Reiberger, Georg Stary and Giulio Superti-Furga. Andreas Villunger is affiliated with the Medical University of Innsbruck, Kaan Boztug and Davide Seruggia with the Children's Cancer Research Institute (CCRI) in Vienna. As we see interdisciplinary as a fundamental pillar for excellence, close cooperation with the fields of chemistry, physics, and network science plays an important role at CeMM. Therefore, 2 Adjunct Principal Investigators, Nuno Maulide, Jörg Menche, have dual affiliations with the University of Vienna, our Adjunct PI Miriam Unterlass is affiliated with the University of Konstanz.